Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study
- 26 March 2020
- Vol. 69 (12), 2223-2231
- https://doi.org/10.1136/gutjnl-2019-320007
Abstract
Objective Population-based studies demonstrating the clinical impact of interferon-free direct-acting antiviral (DAA) therapies are lacking. We examined the impact of the introduction of DAAs on HCV-related decompensated cirrhosis (DC) through analysis of population-based data from Scotland. Design Through analysis of national surveillance data (involving linkage of HCV diagnosis and clinical databases to hospital and deaths registers), we determined i) the scale-up in the number of patients treated and achieving a sustained viral response (SVR), and ii) the change in the trend of new presentations with HCV-related DC, with the introduction of DAAs. Results Approximately 11 000 patients had been treated in Scotland over the 8-year period 2010/11 to 2017/18. The scale-up in the number of patients achieving SVR between the pre-DAA and DAA eras was 2.3-fold overall and 5.9-fold among those with compensated cirrhosis (the group at immediate risk of developing DC). In the pre-DAA era, the annual number of HCV-related DC presentations increased 4.6-fold between 2000 (30) and 2014 (142). In the DAA era, presentations decreased by 51% to 69 in 2018 (and by 67% among those with chronic infection at presentation), representing a significant change in trend (rate ratio 0.88, 95% CI 0.85 to 0.90). With the introduction of DAAs, an estimated 330 DC cases had been averted during 2015–18. Conclusions National scale-up in interferon-free DAA treatment is associated with the rapid downturn in presentations of HCV-related DC at the population-level. Major progress in averting HCV-related DC in the short-term is feasible, and thus other countries should strive to achieve the same.Keywords
Funding Information
- Health Protection Scotland (Analytical research to inform on the effectiveness)
This publication has 33 references indexed in Scilit:
- Trends in mortality after diagnosis of hepatitis C virus infection: An international comparison and implications for monitoring the population impact of treatmentJournal of Hepatology, 2015
- Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?Gut, 2014
- Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testingJournal of Epidemiology and Community Health, 2014
- Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: Implications for treatment cost-effectivenessJournal of Hepatology, 2012
- Multiple imputation using chained equations: Issues and guidance for practiceStatistics in Medicine, 2010
- Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage studyEuropean Journal of Gastroenterology & Hepatology, 2010
- Imputing missing covariate values for the Cox modelStatistics in Medicine, 2009
- Comparison of deaths related to Hepatitis C and AIDS in ScotlandJournal of Viral Hepatitis, 2007
- Modeling the current and future disease burden of hepatitis C among injection drug users in ScotlandJournal of Hepatology, 2005
- Segmented regression analysis of interrupted time series studies in medication use researchJournal of Clinical Pharmacy & Therapeutics, 2002